Revolution Medicines, Inc. (FRA:42Z)
Germany flag Germany · Delayed Price · Currency is EUR
67.00
+1.00 (1.52%)
Last updated: Dec 5, 2025, 8:02 AM CET

Revolution Medicines Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
13,2347,8074,2701,9791,6312,148
Upgrade
Market Cap Growth
53.31%82.84%115.76%21.35%-24.09%-
Upgrade
Enterprise Value
11,9316,3943,5911,4271,1241,795
Upgrade
Last Close Price
67.0041.8026.4022.2022.8032.60
Upgrade
PS Ratio
--407.5859.7863.1161.14
Upgrade
PB Ratio
9.723.572.583.093.085.54
Upgrade
P/TBV Ratio
10.173.682.693.463.516.58
Upgrade
EV/Sales Ratio
--342.7843.1143.4851.07
Upgrade
Debt / Equity Ratio
0.260.060.050.090.110.07
Upgrade
Asset Turnover
--0.010.050.050.11
Upgrade
Quick Ratio
7.8613.9712.8910.489.669.48
Upgrade
Current Ratio
8.0514.2013.0610.659.779.63
Upgrade
Return on Equity (ROE)
-60.76%-29.33%-34.75%-38.63%-34.73%-34.49%
Upgrade
Return on Assets (ROA)
-32.29%-18.66%-20.08%-20.83%-18.00%-17.56%
Upgrade
Return on Capital (ROIC)
-35.37%-19.97%-21.67%-22.76%-19.98%-20.96%
Upgrade
Return on Capital Employed (ROCE)
-51.70%-28.80%-24.10%-34.40%-27.70%-21.30%
Upgrade
Earnings Yield
-6.19%-7.42%-9.25%-11.76%-10.09%-4.12%
Upgrade
FCF Yield
-5.00%-7.02%-7.59%-11.12%-8.29%-3.92%
Upgrade
Buyback Yield / Dilution
-15.98%-48.24%-40.34%-10.74%-32.68%-1879.16%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.